ArticleBiochemical pharmacology2015

Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.

Yong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.